These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7932170)

  • 21. Phase I dose-finding study and a pharmacokinetic/pharmacodynamic analysis of the neutropenic response of intravenous diflomotecan in patients with advanced malignant tumours.
    Trocòniz IF; Garrido MJ; Segura C; Cendrós JM; Principe P; Peraire C; Obach R
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):727-35. PubMed ID: 16261364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thiol adducts of ethacrynic acid: a correlation of the rate of liberation of ethacrynic acid with the onset and magnitude of the diuretic response.
    Koechel DA; Cafruny EJ
    J Pharmacol Exp Ther; 1975 Jan; 192(1):179-94. PubMed ID: 1123723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic-pharmacodynamic integration of danofloxacin after intravenous, intramuscular and subcutaneous administration to rabbits.
    Fernández-Varón E; Marin P; Escudero E; Vancraeynest D; Cárceles CM
    J Vet Pharmacol Ther; 2007 Feb; 30(1):18-24. PubMed ID: 17217396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of food on the pharmacokinetics of S-1 after single oral administration to patients with solid tumors.
    Peters GJ; Noordhuis P; Van Groeningen CJ; Giaccone G; Holwerda U; Voorn D; Schrijvers A; Schornagel JH; Beijnen JH; Fumoleau P; Schellens JH
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4072-6. PubMed ID: 15217941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of inhibiting cytochrome P450 3A, p-glycoprotein, and gastric acid secretion on the oral bioavailability of methadone in dogs.
    Kukanich B; Lascelles BD; Aman AM; Mealey KL; Papich MG
    J Vet Pharmacol Ther; 2005 Oct; 28(5):461-6. PubMed ID: 16207309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The relative bioavailability and pharmacokinetics of chloral hydrate and its metabolites].
    Zimmermann T; Wehling M; Schulz HU
    Arzneimittelforschung; 1998 Jan; 48(1):5-12. PubMed ID: 9522024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized crossover pharmacokinetic evaluation of subcutaneous versus intravenous granisetron in cancer patients treated with platinum-based chemotherapy.
    Gurpide A; Sadaba B; Martin-Algarra S; Azanza JR; Lopez-Picazo JM; Campanero MA; Cabello JP; Gil-Aldea I; de la Cruz S; Fernandez Gallego V; Reyna C; Olier Garate C; Blanco-Prieto MJ; Ceballos J; Garcia-Foncillas J; Perez-Gracia JL
    Oncologist; 2007 Sep; 12(9):1151-5. PubMed ID: 17914085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Brief report on our present experience with ethacrynic acid s a diuretic agent].
    Jürgens WW; Kunze D; Parsi RA
    Dtsch Gesundheitsw; 1968 Aug; 23(33):1544-6. PubMed ID: 5685937
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of Ethacrynic Acid Addition to Diet on Fitness and Development in the Psocid Liposcelis bostrychophila Badonnel.
    Dou W; Wu JJ; Chen SC; Wei DD; Wang JJ
    Environ Entomol; 2016 Feb; 45(1):252-7. PubMed ID: 26475825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethacrynic acid diuretic effect in 50 patients.
    Helal SM
    J Egypt Med Assoc; 1968; 51(10):857-63. PubMed ID: 5736310
    [No Abstract]   [Full Text] [Related]  

  • 32. [Diuretic effects of ethacrynic acid (A.E.C.). I. In administration limited to 24 hours].
    Isorni P; Danvy F; Cibault G
    Actual Cardiol Angeiol Int (Paris); 1966; 15(4):237-40. PubMed ID: 5985593
    [No Abstract]   [Full Text] [Related]  

  • 33. [Study of a new diuretic: ethacrynic acid, apropos of 50 cases].
    Herbeuval R; Guerci O; Gurecki H
    Therapie; 1965; 20(4):997-1013. PubMed ID: 5845211
    [No Abstract]   [Full Text] [Related]  

  • 34. Diuretic effect of ethacrynic acid.
    Practitioner; 1966 Sep; 197(179):365-9. PubMed ID: 5916204
    [No Abstract]   [Full Text] [Related]  

  • 35. [Diuretic effect of ethacrynic acid in hypervasopressinism states].
    De Sousa RC; Jenny M; Delaere J
    Rev Fr Etud Clin Biol; 1966 Feb; 11(2):189-92. PubMed ID: 5932456
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical experience with a new and potent diuretic (ethacrynic acid).
    Aravanis C; Antonakis E; Michaelides G
    Mal Cardiovasc; 1966; 7(4):643-52. PubMed ID: 5990293
    [No Abstract]   [Full Text] [Related]  

  • 37. Ethacrynic acid, a potent diuretic.
    Stillman MT
    Minn Med; 1967 Apr; 50(4):573-85. PubMed ID: 6042277
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of Edecrine in obstetrics].
    Mahon R; Dubecq JP; Baudet E; Coqueran J
    Bull Fed Soc Gynecol Obstet Lang Fr; 1968; 20(5):440-2. PubMed ID: 5759113
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ethacrynic acid in the treatment of arterial hypertension].
    Alestig K; Lundvall O; Sannerstedt R
    Lakartidningen; 1966 Dec; 63(52):4985-8. PubMed ID: 5981274
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical experience with ethacrynic acid].
    Lundvall O; Sannerstedt R; Schröder G
    Lakartidningen; 1965 Jun; 62():Suppl 1: 53-61. PubMed ID: 5868610
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.